Company / Interest Expense per Share
Gilead Sciences Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.80
FY2023
5-year range
$0.78 / $0.80
FY2019-FY2023
Trend
+2.3%
vs FY2022
Sector context
#10 of 43
Health Care
What the data says
Gilead Sciences's interest expense per share of $0.80 is higher than 77% of companies in the Health Care sector (FY2023). Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.29 in FY2016 to $0.87 in FY2019.
Based on SEC 10-K filings.
0.80 in FY2023 with a 5-year CAGR of +1.7%. Top quartile in the Health Care sector.
Remained stable around $0.80 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +1.7%
- 10-Year CAGR
- -
Sector benchmark
-95.7% below sector average
Key checks
Key Insights
- In FY2023, interest expense per share increased 2.3% year-over-year.
- Ranks #10 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2019.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 27.9%
- Strong return on equity: 37.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.80 | +2.3% |
| FY2022 | $0.78 | -1.1% |
| FY2021 | $0.79 | +2.1% |
| FY2020 | $0.78 | -10.9% |
| FY2019 | $0.87 | +18.3% |
| FY2018 | $0.74 | +40.3% |
| FY2017 | $0.53 | +81.3% |
| FY2016 | $0.29 | -36.9% |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026